Description
The video transcript features Ian Murray as he discusses the emerging field of orthobiologics, presenting a deep dive into its applications, challenges, and the underlying scientific rationale. He emphasizes the growing popularity of orthobiologics, particularly due to the potential for tissue regeneration through various strategies like growth factors and cell therapies. Despite its burgeoning market, valued at £4.8 billion in 2018, Murray highlights significant controversies and the current lack of robust evidence supporting many treatments, urging for a more informed and transparent approach in communication with patients and the healthcare community regarding their use. He also distinguishes between different types of cell therapies, specifically platelet-rich plasma and mesenchymal stem cells, addressing the variability in their effectiveness and the importance of reliable preparation methods. The talk concludes with a call for better transparency and patient education, recognizing biologics as a frontier in treating musculoskeletal injuries while cautioning against misleading marketing practices.
DOI: 10.1302/3114-210693